IINN

Inspira Technologies Oxy B.H.N. Ltd. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website inspira-technologies.com
Employees(FY) 32
ISIN IL0011715781

Performance

-25.51%

-30.46%

-29.36%

-45.39%

-16.03%

YTD

-19.81%

Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Advanced Technical Analysis

Technical Analysis of IINN 2024-12-20

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 3, Oscillators Score at 36, and a Technical Score of 20, indicating overall weakness in price momentum and suggesting caution for potential investors. The low scores across all categories reinforce a negative outlook for the stock in the near term.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of IINN

Stock Rank

Recent News & Updates

2024-12-15 19:30
Inspira Technologies Delivers Systems to Leading Distributor for U.S. Deployment(Prnewswire)
2024-12-09 19:00
Inspira Expands HYLA Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions(Prnewswire)
2024-12-03 18:00
Inspira Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA ART100 Functionality and Performance in Clinical Scenarios(Prnewswire)
2024-11-07 20:11
Join Inspira Technologies' Live Investor Webinar and Q&A Session on November 11(Prnewswire)
2024-10-24 00:17
/C O R R E C T I O N -- Inspira Technologies/(Yahoo Finance)
2024-10-23 20:30
Inspira Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA ART100(Prnewswire)
2024-10-08 20:00
Inspira Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism(Prnewswire)
2024-09-23 20:30
Inspira Launches INSPIRA ART100 at the World's Largest Extracorporeal Life Support Conference(Prnewswire)
2024-09-12 19:30
Inspira Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System(Prnewswire)
2024-08-27 20:45
Inspira to Publish HYLA Clinical Results in Fourth Quarter 2024(Prnewswire)
2024-08-21 20:00
Inspira Technologies Announces FDA Listing and Market Readiness of New Product(Prnewswire)
2024-08-12 20:00
Inspira Approached by Large Medical Company to Evaluate Operation of their Key Product with INSPIRA ART100 - Results Exceed 100% at Maximum Flow(Prnewswire)
2024-07-29 19:30
Inspira Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest(Prnewswire)
2024-07-10 20:30
Inspira Receives Israeli Regulatory Approval for the INSPIRA ART100 System(Prnewswire)
2024-06-20 23:12
Inspira (IINN) Unveils Business Targets for 2024-25(Zacks)
2024-06-19 21:25
Inspira Announces Business Plan Targets(Prnewswire)
2024-06-16 20:30
Inspira Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel(Yahoo Finance)
2024-06-16 20:30
Inspira Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel(Prnewswire)
2024-06-12 20:30
Inspira Receives First Ever Purchase Order for INSPIRA ART100 Systems in the U.S.(Prnewswire)
2024-06-04 20:30
Inspira to Exhibit the FDA Cleared INSPIRA ART100 System at a World-Renowned Event in the Sector(Prnewswire)
2024-05-29 20:30
Inspira Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments(Prnewswire)
2024-05-29 00:13
Inspira Technologies' (IINN) ART100 Gets FDA 510(k) Grant(Zacks)
2024-05-27 21:25
INSPIRA ART100 Receives FDA 510(k) Clearance(Prnewswire)
2024-05-01 21:18
Inspira Announces Start of Production of the INSPIRA ART100(Prnewswire)
2024-04-24 20:00
Inspira Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA ART100(Prnewswire)
2024-04-15 20:42
Inspira Signs Term Sheet for Use of INSPIRA ART100 Device in Organ Transplant Procedures(Prnewswire)
2024-04-09 20:24
Inspira and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections(Prnewswire)
2024-04-02 20:30
Inspira Announces Program to Pioneer the Applicable Use of the INSPIRA ART100 Device for an Artificial Womb(Prnewswire)
2024-03-31 20:00
Inspira Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager(Prnewswire)
2024-03-25 01:52
IINN Stock Earnings: Inspira Technologies Oxy Beats EPS for Q4 2022(Investorplace)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.